Published in Transplant Proc on March 01, 1973
Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg (2003) 3.14
Impact of blood transfusion on renal transplantation. Ann Surg (1978) 0.78
General surgery in patients on maintenance hemodialysis. Ann Surg (1974) 0.75
Specific suppression of organ graft rejection. Proc R Soc Med (1976) 0.75
Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation (1973) 6.01
Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties. J Immunol (1966) 5.59
Transplantation of small bowel in the rat: technical and immunological considerations. Surgery (1971) 5.05
Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response. J Immunol (1966) 4.49
Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med (1981) 3.63
HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science (1988) 3.12
Adult Thymectomy: Effect on Recovery from Immunologic Depression in Mice. Science (1965) 2.41
The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J Clin Invest (1972) 2.38
DEPRESSION BY ANTIBODY OF THE IMMUNE RESPONSE TO HOMOGRAFTS AND ITS ROLE IN IMMUNOLOGICAL ENHANCEMENT. J Exp Med (1960) 2.35
Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J Exp Med (1985) 2.34
Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation (1981) 2.22
Improved survival from acute renal failure after treatment with intravenous essential L-amino acids and glucose. Results of a prospective, double-blind study. N Engl J Med (1973) 2.18
The immunologic response to xenografts. Recognition of mouse H-2 histocompatibility antigens by the rat. J Immunol (1971) 2.17
A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant (2011) 2.16
Heart transplantation in congenic strains of mice. Transplant Proc (1973) 1.97
Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants. J Exp Med (1978) 1.95
Reaction of human lymphocytes in culture to components of the medium. Nature (1965) 1.92
Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83
Antiserum to lymphocytes: prolonged survival of canine renal allografts. Science (1966) 1.81
Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med (1981) 1.77
Humoral antibodies in renal allotransplantation in man. N Engl J Med (1970) 1.74
A closer look at water-related geologic activity on Mars. Science (2007) 1.71
Some effects of purified heterologous antihuman lymphocyte serum in man. Transplantation (1967) 1.62
Effect of adult thymectomy on the recovery from immunological depression induced by anti-lymphocyte serum. Surg Forum (1965) 1.60
Athabasca Valles, Mars: a lava-draped channel system. Science (2007) 1.58
Procurement of a whole pancreas and liver from the same cadaveric donor. Surgery (1989) 1.49
Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol (1994) 1.45
In vivo use of monoclonal antibodies against murine T cell antigens. Clin Immunol Immunopathol (1989) 1.41
Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation (1977) 1.40
All-silica single-mode optical fiber with photonic crystal cladding. Opt Lett (1996) 1.39
Plasma interleukin 2 receptor levels in renal allograft recipients. Clin Immunol Immunopathol (1987) 1.38
Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection. J Immunol (1985) 1.37
Skin graft rejection by beta 2-microglobulin-deficient mice. J Exp Med (1992) 1.37
Fibronectin is produced by blood vessels in response to injury. J Exp Med (1982) 1.35
Etiology, incidence, and prognosis of renal failure following cardiac operations. Results of a prospective analysis of 500 consecutive patients. J Thorac Cardiovasc Surg (1976) 1.34
Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5. J Immunol (1982) 1.34
Supercontinuum generation in tapered fibers. Opt Lett (2000) 1.31
Hyperparathyroidism during pregnancy. Am J Surg (1976) 1.29
Kidney transplants between mice of graded immunogenetic diversity. Transplant Proc (1973) 1.29
Peripheral lymphoid development and function in TCR mutant mice. Int Immunol (1994) 1.26
Immunosuppression and temporary skin transplantation in the treatment of massive third degree burns. Ann Surg (1975) 1.26
Xenogeneic proliferation and lymphokine production are dependent on CD4+ helper T cells and self antigen-presenting cells in the mouse. J Exp Med (1990) 1.26
Heterologous antilymphocyte sera and some of their effects. Transplantation (1967) 1.25
Removal of 3'-phosphoglycolate from DNA strand-break damage in an oligonucleotide substrate by recombinant human apurinic/apyrimidinic endonuclease 1. Nucleic Acids Res (1994) 1.24
Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression. Transplantation (1986) 1.24
Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp Med (1994) 1.24
Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am J Transplant (2010) 1.23
Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med (1983) 1.23
Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. Am J Pathol (1994) 1.22
Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection. Transplantation (1984) 1.20
Temporary skin transplantation and immunosuppression for extensive burns. N Engl J Med (1974) 1.19
Acute destruction by humoral antibody of rat skin grafted to mice. J Immunol (1973) 1.19
A technique for reconstruction of the urinary tract in renal transplantation. Surg Gynecol Obstet (1966) 1.19
The vascular bed as the primary target in the destruction of skin grafts by antiserum. I. Resistance of freshly placed xenografts of skin to antiserum. J Exp Med (1981) 1.18
Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients. N Engl J Med (1983) 1.18
Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis. Am J Transplant (2007) 1.18
Effects of antithymocyte globulin on cytomegalovirus infection in renal transplant recipients. Transplantation (1981) 1.18
Macrophage depletion suppresses cardiac allograft vasculopathy in mice. Am J Transplant (2007) 1.17
Induction of IA antigens in murine renal transplants. J Immunol (1985) 1.16
Acute destruction by humoral antibody of rat skin grafted to mice. J Exp Med (1973) 1.15
Analgesia in terminal malignant disease. Br Med J (1979) 1.14
Antilymphocyte serum as an immunosuppressive agent. Ann Intern Med (1968) 1.12
Regulation of human insulin gene expression in transgenic mice. Nature (1986) 1.12
Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-gamma. Transplantation (1994) 1.12
Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivo. Transplantation (1988) 1.12
Studies on natural killer (NK) cells. I. NK cell specific antibodies in CE anti-CBA serum. J Immunol (1981) 1.12
From the National Institutes of Health. Summary of a workshop on cytomegalovirus infections during organ transplantation. J Infect Dis (1979) 1.11
Evaluation in primate renal allograft recipients of monoclonal antibody to human T-cell subclasses. Transplant Proc (1981) 1.11
Endlessly single-mode photonic crystal fiber. Opt Lett (1997) 1.10
Destruction of rat skin grafts by humoral antibody. Transplant Proc (1973) 1.10
The vascular bed as the primary target in the destruction of skin grafts by antiserum. II. Loss of sensitivity to antiserum in long-term xenografts of skin. J Exp Med (1981) 1.10
Variations in the responses of C57BL-10J and A-J mice to sheep red blood cells. J Exp Med (1972) 1.08
Xenogeneic skin graft rejection is especially dependent on CD4+ T cells. J Exp Med (1989) 1.07
A new alloantigenic system associated with the Mls locus in the mouse. J Immunol (1976) 1.07
Antigenic polymorphism of the T4 differentiation antigen expressed on human T helper/inducer lymphocytes. Hum Immunol (1984) 1.06
Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis. J Neurol Sci (1974) 1.05
T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection. Immunol Res (1989) 1.05
The effect of infection on T lymphocyte subpopulations: a preliminary report. Int J Immunopharmacol (1981) 1.04
Acute destruction of rat skin grafts by alloantisera. J Immunol (1975) 1.03
Prevalence of eating disorders and psychiatric comorbidity among children and adolescents. Indian Pediatr (2007) 1.02
Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway. Am J Transplant (2009) 1.02
Sensitivity of long-standing xenografts of rat hearts to humoral antibodies. J Immunol (1979) 1.02
Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies. Transplantation (1982) 1.01
The renal transplant patient with fever and pulmonary infiltrates: etiology, clinical manifestations, and management. Medicine (Baltimore) (1980) 1.01
Destruction of splenic transplantation antigens by a factor present in liver. J Immunol (1965) 1.01
Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring. Surgery (1976) 1.00